A new paper from @WilsonLab2 @TimmKoller @MartinoMorici reports structures of the O-glycosylated antimicrobial peptide Drosocin in complex with the bacterial ribosome, revealing how Drosocin inhibits the termination phase of protein synthesis. Open access: https://t.co/O6mKxVyB4b
@pdhsu Precise Integration of Inducible Transcriptional Elements (PRIITE) enables absolute control of gene expression. For more information check out R.Pinto et al., NAR, 2017!
Excited to announce that my lab is moving this fall to @BerkeleyBioE. We develop new biotechnologies (and not just CRISPR-Cas!) to control brain and immune cell function for improving human health. Hiring at all levels (postdocs, grad students, RAs) - https://t.co/MFhG34kwWm
After overwhelming interest and thanks to great talks by: Samantha Maragh, Roberto Nitsch, Marcello Maresca, Jason Potter, Casey Jowdy, Kevin Holden, and others, this years 6th annual Precision CRISPR mini-symposium, became a great success. Heads up for our next event, next year!
Thanks to all students for a successful end of the 4th bi-annual 2 week Ph.D Course “Gene Targeting and Editing”. Students gained hands-on experience with anti-sense, CRISPR/Cas9 in bacteria, CRISPR/Cas9, ZFN and TALEN in mammalian cells and learn how to perform T7EI and IDAA.
The full program for the forthcoming “Precision CRISPR: Applications, Standardization and Reproducibility of Genome Editing��, mini-symposium is now available. Interest has been overwhelming and we look forward to an exciting event with presentations from…https://t.co/Nc4IVTMwbH
Pleased to welcome You All to our yearly CRISPR mini-symposium entitled: “Precision CRISPR: Applications, Standardization and Reproducibility of Genome Editing”, Mini-symposium, August 30th, 2019!
https://t.co/B8qARv5BKA
Great opportunity for pre- and post –graduate students to catch up on the basics and translational aspects of CRISPR/Cas9 gene editing!
https://t.co/pk5b1qLigc
Cobo Technologies has been enrolled in the US NIST Genome Editing Consortium. A great opportunity for Cobo Technologies to contribute and interact on establishing guidelines and “best practice” procedures for measuring genome editing outcomes.
https://t.co/Hix7W3ilnK
Instant identification and quantification of ex vivo CRISPR/Cas9 editing outcomes in primary cells! Our detailed protocol can be found in the "CRISPR Gene Editing methods and Protocols" collection that is finally out.
https://t.co/WXy5UXVCuq
Looking forward to present and network at the Therapeutic Genome Editing Congress, March 20th-21st in Boston, with presence of leading institutions in the genome editing field.
https://t.co/8Me86yliff